Published in Am J Pathol on July 01, 2004
Immunologic regulation in pregnancy: from mechanism to therapeutic strategy for immunomodulation. Clin Dev Immunol (2011) 0.91
Signaling pathways for B cell-activating factor (BAFF) and a proliferation-inducing ligand (APRIL) in human placenta. Am J Pathol (2008) 0.89
Excess LIGHT contributes to placental impairment, increased secretion of vasoactive factors, hypertension, and proteinuria in preeclampsia. Hypertension (2013) 0.86
Elevated serum decoy receptor 3 with enhanced T cell activation in systemic lupus erythematosus. Clin Exp Immunol (2008) 0.86
Aberrant expression and function of death receptor-3 and death decoy receptor-3 in human cancer. Exp Ther Med (2011) 0.81
Significance of increased expression of decoy receptor 3 in chronic liver disease. Dig Liver Dis (2009) 0.80
Elevated Serum Levels of the Antiapoptotic Protein Decoy-Receptor 3 Are Associated with Advanced Liver Disease. Can J Gastroenterol Hepatol (2016) 0.77
NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science (1998) 11.70
IAP proteins: blocking the road to death's door. Nat Rev Mol Cell Biol (2002) 7.23
Expression of human immune interferon cDNA in E. coli and monkey cells. Nature (1982) 6.55
TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40. Science (1995) 6.41
Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae. Endocrinology (1986) 4.89
LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator. Immunity (1998) 4.23
Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature (1998) 2.98
Activation of NF-kappaB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications. Oncogene (2002) 2.66
LIGHT, a TNF-like molecule, costimulates T cell proliferation and is required for dendritic cell-mediated allogeneic T cell response. J Immunol (2000) 2.27
The inhibitor of apoptosis, cIAP2, functions as a ubiquitin-protein ligase and promotes in vitro monoubiquitination of caspases 3 and 7. J Biol Chem (2000) 2.21
Modulation of T-cell-mediated immunity in tumor and graft-versus-host disease models through the LIGHT co-stimulatory pathway. Nat Med (2000) 2.18
A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis. J Biol Chem (1999) 1.98
LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer. J Clin Invest (1998) 1.89
The lymphotoxin-beta receptor is necessary and sufficient for LIGHT-mediated apoptosis of tumor cells. J Biol Chem (2000) 1.84
Herpesvirus entry mediator ligand (HVEM-L), a novel ligand for HVEM/TR2, stimulates proliferation of T cells and inhibits HT29 cell growth. J Biol Chem (1998) 1.60
TRAIL induced survival and proliferation in cancer cells resistant towards TRAIL-induced apoptosis mediated by NF-kappaB. Oncogene (2003) 1.57
Villous cytotrophoblast regulation of the syncytial apoptotic cascade in the human placenta. Histochem Cell Biol (1998) 1.53
Fas ligand is positioned in mouse uterus and placenta to prevent trafficking of activated leukocytes between the mother and the conceptus. J Immunol (1997) 1.51
Involvement of two NF-kappa B binding elements in tumor necrosis factor alpha -, CD40-, and epstein-barr virus latent membrane protein 1-mediated induction of the cellular inhibitor of apoptosis protein 2 gene. J Biol Chem (2000) 1.46
Interferon-gamma modulates a p53-independent apoptotic pathway and apoptosis-related gene expression. J Biol Chem (1997) 1.46
Reciprocal expression of the TNF family receptor herpes virus entry mediator and its ligand LIGHT on activated T cells: LIGHT down-regulates its own receptor. J Immunol (2000) 1.42
Tumor necrosis factor induces DNA replication in hepatic cells through nuclear factor kappaB activation. Cell Growth Differ (1999) 1.37
Cytotoxicity of tumour necrosis factor-alpha and gamma-interferon against primary human placental trophoblasts. Placenta (1994) 1.34
Death-inducing tumour necrosis factor (TNF) superfamily ligands and receptors are transcribed in human placentae, cytotrophoblasts, placental macrophages and placental cell lines. Placenta (2001) 1.28
TRAIL (Apo-2L) and TRAIL receptors in human placentas: implications for immune privilege. J Immunol (1999) 1.25
Genomic characterization of LIGHT reveals linkage to an immune response locus on chromosome 19p13.3 and distinct isoforms generated by alternate splicing or proteolysis. J Immunol (2001) 1.24
Isolation of pure villous cytotrophoblast from term human placenta using immunomagnetic microspheres. J Immunol Methods (1989) 1.18
Apoptosis cascade progresses during turnover of human trophoblast: analysis of villous cytotrophoblast and syncytial fragments in vitro. Lab Invest (1999) 1.12
Expression of Fas ligand by human cytotrophoblasts: implications in placentation and fetal survival. J Clin Endocrinol Metab (1996) 1.08
Tumor necrosis factors: pivotal components of pregnancy? Biol Reprod (1996) 1.05
Effects of tumour necrosis factor-alpha, interleukin-1 alpha, macrophage colony stimulating factor and transforming growth factor beta on trophoblastic matrix metalloproteinases. Mol Hum Reprod (1999) 1.02
Differential regulation and function of the Fas/Fas ligand system in human trophoblast cells. Biol Reprod (2002) 0.98
Tumor necrosis factor-alpha mRNA and protein in rat uterine and placental cells. J Immunol (1991) 0.92
Tumor necrosis factor-alpha-induced lung cell expression of antiapoptotic genes TRAF1 and cIAP2. Am J Respir Cell Mol Biol (2000) 0.91
Temporal and spatial patterns of expression of inhibitors of apoptosis in human placentas. Am J Pathol (2003) 0.90
The C-terminal activation domain of the STAT-1 transcription factor is necessary and sufficient for stress-induced apoptosis. Cell Death Differ (2002) 0.90
Overexpression of bcl-2 enhances LIGHT- and interferon-gamma -mediated apoptosis in Hep3BT2 cells. J Biol Chem (2000) 0.89
LIGHT, a member of the tumor necrosis factor ligand superfamily, prevents tumor necrosis factor-alpha-mediated human primary hepatocyte apoptosis, but not Fas-mediated apoptosis. J Biol Chem (2002) 0.88
Interferon gamma expression during human pregnancy and in association with labour. Gynecol Obstet Invest (1999) 0.87
Localization of IFN-gamma receptor in first trimester placenta to trophoblasts but lack of stimulation of HLA-DRA, -DRB, or invariant chain mRNA expression by IFN-gamma. J Immunol (1992) 0.86
Tumor necrosis factor-alpha inhibits human chorionic gonadotropin secretion. J Clin Endocrinol Metab (1992) 0.85
Differential expression of LIGHT and its receptors in human placental villi and amniochorion membranes. Am J Pathol (2002) 0.85
Modulation of trophoblast function by tumor necrosis factor-alpha: a role in pregnancy establishment and maintenance? Am J Obstet Gynecol (2002) 0.84
First trimester human trophoblast expresses both interferon-gamma and interferon-gamma-receptor. J Reprod Immunol (1994) 0.84
Normal distribution of tumor necrosis factor-alpha messenger ribonucleic acid and protein in the uteri, placentas, and embryos of osteopetrotic (op/op) mice lacking colony-stimulating factor-1. Biol Reprod (1993) 0.83
Death receptor Fas/Apo-1/CD95 expressed by human placental cytotrophoblasts does not mediate apoptosis. Biol Reprod (1999) 0.83
The cytoplasmic domain of the lymphotoxin-beta receptor mediates cell death in HeLa cells. J Biol Chem (1999) 0.80
Distribution of type-I interferon-receptors in human first trimester and term placental tissues and on isolated trophoblast cells. Am J Reprod Immunol (1997) 0.78
Light stimulates IFNgamma-mediated intercellular adhesion molecule-1 upregulation of cancer cells. Hum Immunol (2003) 0.77
Fine mapping and positional candidate studies identify HLA-G as an asthma susceptibility gene on chromosome 6p21. Am J Hum Genet (2004) 2.03
Programming of human monocytes by the uteroplacental environment. Reprod Sci (2008) 1.69
Transcriptional regulation of VEGF-A by the unfolded protein response pathway. PLoS One (2010) 1.52
B7 family molecules are favorably positioned at the human maternal-fetal interface. Biol Reprod (2002) 1.49
Investigation of an antibody reported to identify leukocyte immunoglobulin-like receptors (LILRB2) on placental vascular smooth muscle. Placenta (2009) 1.38
Isolation and culture of term human trophoblast cells. Methods Mol Med (2006) 1.23
Trophoblast CD274 (B7-H1) is differentially expressed across gestation: influence of oxygen concentration. Biol Reprod (2005) 1.14
Placental cell expression of HLA-G2 isoforms is limited to the invasive trophoblast phenotype. J Immunol (2003) 1.07
Synthesis of beta(2)-microglobulin-free, disulphide-linked HLA-G5 homodimers in human placental villous cytotrophoblast cells. Immunology (2007) 1.06
Characteristics of the fetal/maternal interface with potential usefulness in the development of future immunological and pharmacological strategies. J Pharmacol Exp Ther (2002) 1.01
Decidual macrophages are potentially susceptible to inhibition by class Ia and class Ib HLA molecules. J Reprod Immunol (2002) 0.98
Recombinant HLA-G5 and -G6 drive U937 myelomonocytic cell production of TGF-beta1. J Leukoc Biol (2004) 0.98
Temporal and spatial patterns of expression of inhibitors of apoptosis in human placentas. Am J Pathol (2003) 0.90
Signaling pathways for B cell-activating factor (BAFF) and a proliferation-inducing ligand (APRIL) in human placenta. Am J Pathol (2008) 0.89
In vitro models for studying human uterine and placental macrophages. Methods Mol Med (2006) 0.86
Cell-specific expression of B lymphocyte (APRIL, BLyS)- and Th2 (CD30L/CD153)-promoting tumor necrosis factor superfamily ligands in human placentas. J Leukoc Biol (2003) 0.86
Analysis of the soluble isoforms of HLA-G mRNAs and proteins. Methods Mol Med (2006) 0.85
Differential expression of LIGHT and its receptors in human placental villi and amniochorion membranes. Am J Pathol (2002) 0.85
Differential expression of human leukocyte antigen-G (HLA-G) messenger RNAs and proteins in normal human prostate and prostatic adenocarcinoma. J Reprod Immunol (2006) 0.84
Potential regulatory sequences in the untranslated regions of the baboon MHC class Ib gene, Paan-AG, more closely resemble those in the human MHC class Ia genes than those in the class Ib gene, HLA-G. Immunogenetics (2004) 0.82
Baboon placentas express soluble and membrane-bound Paan-AG proteins encoded by alternatively spliced transcripts of the class Ib major histocompatibility complex gene, Paan-AG. Immunogenetics (2002) 0.81
Differential cellular expression of LIGHT and its receptors in early gestation human placentas. J Reprod Immunol (2006) 0.81
Do nonhuman primates comprise appropriate experimental models for studying the function of human leukocyte antigen-G? Biol Reprod (2002) 0.79
Placenta and trophoblast: methods and protocols: overview II. Methods Mol Med (2006) 0.78
Methods for evaluating histocompatibility antigen gene expression in the baboon. Methods Mol Med (2006) 0.75